Shampoo Allergy: Why SLS Is an Irritant and CAPB Is the True Allergen

Scalp itching after shampooing can reflect either irritant contact dermatitis (ICD) or allergic contact dermatitis (ACD), and the timing helps distinguish them. If the itch starts during or immediately after washing and resolves within a few hours, SLS irritation is more likely — dose-dependent, non-immune, resolved by barrier recovery. If the itch develops or worsens 24–72 hours after shampooing, particularly with redness, scaling, or a drip-pattern rash on the neck and behind the ears, allergic contact dermatitis to CAPB, MI, or a formaldehyde releaser is more probable. A 4-week washout with a minimal-allergen baby shampoo or syndet bar that is fragrance-free and CAPB-free, followed by patch testing if symptoms persist, will clarify the mechanism and guide treatment.

True IgE-mediated or Type IV allergic sensitization to SLS (sodium lauryl sulfate) or SLES (sodium laureth sulfate) is not established in published patch-test literature. These anionic surfactants cause irritant contact dermatitis through direct dose-dependent barrier disruption — a physical and chemical effect, not an immune response. Patients who report sulfate allergy are virtually always experiencing irritant reactions: scalp tightness, burning, dryness that resolves with barrier-protecting conditioner and reduced washing frequency. This distinction matters because 'sulfate-free' shampoos typically substitute CAPB (a true contact allergen at 3–7.2% sensitization) and keep MI or formaldehyde releasers in the preservative system — so switching without ingredient-level verification rarely resolves genuine allergic scalp reactions.

The principal shampoo contact allergens, based on NACDG and European patch-test data, are: cocamidopropyl betaine (CAPB) — 2004 ACDS Allergen of the Year, 3–7.2% sensitization from impurities amidoamine and DMAPA; methylisothiazolinone (MI) — 11.5% positivity in NACDG 2021–22; formaldehyde-releasing preservatives — DMDM hydantoin, quaternium-15 (highest clinical relevance 55.67%), imidazolidinyl urea, diazolidinyl urea, and bronopol; fragrance components including linalool hydroperoxides and limonene; and propylene glycol. SLS is notably absent from this list because it causes irritant, not allergic, reactions. A comprehensive NACDG-style patch test with preservative supplemental series is the only reliable way to identify which specific allergen is driving a given patient's reaction.

Sulfate-free shampoo is less irritating for most scalps because it removes SLS, the principal scalp barrier irritant. However, it is not inherently less allergenic — most sulfate-free shampoos substitute cocamidopropyl betaine (CAPB) as the primary cleanser and retain MI, fragrance, or formaldehyde releasers in the preservative system. For patients with confirmed CAPB allergy, sulfate-free shampoos are actually more likely to contain high concentrations of their specific allergen than traditional SLS-based formulas, which used SLS as the primary cleanser and less CAPB. The correct approach is not to seek sulfate-free products specifically but to read the INCI label for the confirmed allergen class — CAPB, MI, or formaldehyde releaser — regardless of whether the product is marketed as sulfate-free.

Yes — CAPB sensitization is well documented and was prominent enough to earn the 2004 ACDS Allergen of the Year designation. The confirmed sensitization prevalence ranges from 3.0–7.2% in patch-tested populations, with the actual allergens being the manufacturing impurities amidoamine and 3-(dimethylamino)propylamine (DMAPA) rather than the CAPB molecule itself. This means that CAPB made with higher purity manufacturing processes may be better tolerated. Patch testing should include CAPB, amidoamine, and DMAPA to capture all variants. CAPB appears in virtually all shampoos, conditioners, body washes, and even some baby products as a secondary cleanser and foam booster — making it one of the most consequential shampoo allergens to diagnose because the restriction is so broad.

Shampoos labeled formaldehyde-free may still contain formaldehyde releasers — preservatives that slowly hydrolyze in aqueous solution to release small amounts of free formaldehyde. The formaldehyde-free label typically means no free formaldehyde was added directly, not that the product is free of formaldehyde-releasing chemistry. Common releasers that evade the label include DMDM hydantoin, quaternium-15, imidazolidinyl urea, diazolidinyl urea, and bronopol. EU cosmetics law bans quaternium-15 and restricts free formaldehyde, but US regulation allows both in personal care products. For patients sensitized to formaldehyde releasers, the only safe approach is reading the INCI list for all five releaser names — not relying on the formaldehyde-free claim on the front label.

Brazilian keratin smoothing treatments cause reactions through two independent mechanisms: direct formaldehyde exposure from the product itself, and ACD from fragrance or preservatives in the shampoo and conditioner system used afterward. The formaldehyde issue is the more serious: multiple independent product analyses have found formaldehyde concentrations of 3–11.5% in Brazilian keratin products labeled as formaldehyde-free (Pierce 2011 J Occup Environ Hyg 8:686). At these concentrations, the formaldehyde vapor released during heat-application steps causes both contact dermatitis and respiratory irritation. This exposure applies to clients receiving the treatment and, at higher levels, to hairdressers performing it regularly. The EU has specific formaldehyde concentration limits for cosmetics; the US has no equivalent binding limit for salon-applied smoothing products.

Hypoallergenic is an unregulated marketing term with no binding US or EU definition — it cannot be used reliably to identify allergen-free shampoos. The only reliable approach for a patient with patch-test-confirmed allergens is to read the INCI ingredient list directly for the specific chemical names of confirmed allergens. For CAPB sensitivity, look for the absence of cocamidopropyl betaine, amidoamine, and dimethylaminopropylamine. For MI sensitivity, confirm no methylisothiazolinone or methylchloroisothiazolinone. For formaldehyde-releaser sensitivity, check for DMDM hydantoin, quaternium-15, imidazolidinyl urea, diazolidinyl urea, and bronopol. A dermatologist or allergist experienced in cosmetic ACD can often provide a list of specific safe product recommendations based on your patch-test results.

Home patch testing of shampoo has limited utility compared to formal dermatological patch testing because shampoo is a rinse-off product and its contact time on skin in normal use is short. Applying shampoo under occlusion on the inner arm for 48 hours creates longer contact than normal use and may produce false-positive irritant reactions due to the detergent concentration. A more practical pre-use screen is the ROAT: apply a small amount of the diluted shampoo to the inner forearm twice daily for 7 days without occlusion, mimicking rinse-off conditions. If you develop redness or itch at the test site at 48–96 hours, the product warrants investigation before scalp use. However, a home ROAT does not replace formal patch testing — it screens the product as a whole, not the individual ingredient.

Sublingual immunotherapy (SLIT drops) does not treat shampoo allergy. Shampoo ACD is Type IV contact dermatitis — a T-cell delayed hypersensitivity to CAPB, MI, or formaldehyde releasers — not an IgE-mast-cell reaction. SLIT retrains the IgE pathway responsible for hay fever, dust mite asthma, and pet dander; it has no mechanism of action against T-cell-mediated contact allergens. No commercial SLIT protocol for CAPB, MI, or formaldehyde releasers exists, and there is no clinical evidence that SLIT reduces contact sensitization to shampoo allergens. The evidence-based treatment is patch testing to identify the specific allergen, followed by strict avoidance and use of confirmed allergen-free shampoo. If you have concurrent respiratory allergies, SLIT for those targets is appropriate independently but will not resolve the scalp contact dermatitis.